269 related articles for article (PubMed ID: 34865701)
41. Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
Rasekh EO; Osman R; Ibraheem D; Madney Y; Radwan E; Gameel A; Abdelhafiz A; Kamel A; Elfishawi S
Ann Hematol; 2021 Mar; 100(3):699-707. PubMed ID: 33230570
[TBL] [Abstract][Full Text] [Related]
42. [Study on the clinical characteristics of 32 patients with mixed phenotype acute leukemia].
Zhang YM; Wu DP; Sun AN; Qiu HY; Sun YM; He GS; Jin ZM; Tang XW; Miao M; Fu ZZ; Han Y; Chen SN; Zhu MQ
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):12-6. PubMed ID: 21429394
[TBL] [Abstract][Full Text] [Related]
43. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).
Khan M; Siddiqi R; Naqvi K
Ann Hematol; 2018 Jun; 97(6):945-953. PubMed ID: 29546454
[TBL] [Abstract][Full Text] [Related]
44. Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.
Cernan M; Szotkowski T; Pikalova Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):234-241. PubMed ID: 28422191
[TBL] [Abstract][Full Text] [Related]
45. [The pathological diagnosis and differential diagnosis of hematopoietic cell tumors of ambiguous lineage].
Li M; Zhu MX; Tian L; Guo LG; Hu K; Gao ZF
Zhonghua Xue Ye Xue Za Zhi; 2021 Mar; 42(3):238-242. PubMed ID: 33910310
[No Abstract] [Full Text] [Related]
46. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
[TBL] [Abstract][Full Text] [Related]
47. Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell Transplantation.
Liu S; Cui Q; Dai H; Song B; Cui W; Xue S; Qiu H; Miao M; Jin Z; Li C; Fu C; Wang Y; Sun A; Chen S; Zhu X; Wu D; Tang X
Transplant Cell Ther; 2021 Jun; 27(6):481.e1-481.e7. PubMed ID: 33785365
[TBL] [Abstract][Full Text] [Related]
48. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
49. Zinc finger protein 384 (
Sudutan T; Erbilgin Y; Hatirnaz Ng O; Karaman S; Karakas Z; Kucukcankurt F; Celkan T; Timur C; Ozdemir GN; Hacısalihoglu S; Gelen SA; Sayitoğlu M
Leuk Lymphoma; 2022 Dec; 63(12):2931-2939. PubMed ID: 35921545
[TBL] [Abstract][Full Text] [Related]
50. Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations.
Mi X; Griffin G; Lee W; Patel S; Ohgami R; Ok CY; Wang S; Geyer JT; Xiao W; Roshal M; Garcia JS; Silverman LB; Sallan SE; Aster JC; Harris MH; Weinberg OK
Am J Hematol; 2018 Nov; 93(11):1358-1367. PubMed ID: 30117174
[TBL] [Abstract][Full Text] [Related]
51. Cytogenetic abnormalities in acute leukaemia of ambiguous lineage: an overview.
Manola KN
Br J Haematol; 2013 Oct; 163(1):24-39. PubMed ID: 23888868
[TBL] [Abstract][Full Text] [Related]
52. T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation.
Dorfman DM; Morgan EA; Pelton A; Unitt C
Hum Pathol; 2017 Jul; 65():166-174. PubMed ID: 28551327
[TBL] [Abstract][Full Text] [Related]
53. Acute myeloid leukemia with mixed phenotype is characterized by stemness transcriptomic signatures and limited lineage plasticity.
Galera P; Dilip D; Derkach A; Chan A; Zhang Y; Persuad S; Mishera T; Liu Y; Famulare C; Gao Q; Mata DA; Arcila M; Geyer MB; Stein E; Dogan A; Levine RL; Roshal M; Glass J; Xiao W
medRxiv; 2023 Nov; ():. PubMed ID: 37961275
[TBL] [Abstract][Full Text] [Related]
54. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
Oberley MJ; Gaynon PS; Bhojwani D; Pulsipher MA; Gardner RA; Hiemenz MC; Ji J; Han J; O'Gorman MRG; Wayne AS; Raca G
Pediatr Blood Cancer; 2018 Sep; 65(9):e27265. PubMed ID: 29797659
[TBL] [Abstract][Full Text] [Related]
55. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
56. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse.
Pui CH; Raimondi SC; Head DR; Schell MJ; Rivera GK; Mirro J; Crist WM; Behm FG
Blood; 1991 Sep; 78(5):1327-37. PubMed ID: 1878594
[TBL] [Abstract][Full Text] [Related]
57. Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations.
Gerr H; Zimmermann M; Schrappe M; Dworzak M; Ludwig WD; Bradtke J; Moericke A; Schabath R; Creutzig U; Reinhardt D
Br J Haematol; 2010 Apr; 149(1):84-92. PubMed ID: 20085575
[TBL] [Abstract][Full Text] [Related]
58. CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases.
Rozenova KA; Jevremovic D; Reichard KK; Nguyen P; Otteson GE; Timm MM; Horna P; Olteanu H; Shi M
Hum Pathol; 2021 Aug; 114():66-73. PubMed ID: 34019867
[TBL] [Abstract][Full Text] [Related]
59. Classification of acute leukemias.
Brunning RD
Semin Diagn Pathol; 2003 Aug; 20(3):142-53. PubMed ID: 14552428
[TBL] [Abstract][Full Text] [Related]
60. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.
Weinberg OK; Seetharam M; Ren L; Alizadeh A; Arber DA
Am J Clin Pathol; 2014 Dec; 142(6):803-8. PubMed ID: 25389334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
